Cargando…

Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis

Blood-brain barrier (BBB) disruption is one of the hallmarks of multiple sclerosis (MS). It is incompletely understood whether BBB disruption is the initial MS event leading to MS lesion formation or whether it is merely a consequence of cellular infiltration in the central nervous system (CNS). The...

Descripción completa

Detalles Bibliográficos
Autor principal:	Waubant, Emmanuelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2006
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850823/ https://www.ncbi.nlm.nih.gov/pubmed/17124345 http://dx.doi.org/10.1155/2006/709869

Ejemplares similares

Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment
por: Balasa, Rodica, et al.
Publicado: (2021)

PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption
por: Yun, Hyung-Mun, et al.
Publicado: (2015)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Biomarkers in Multiple Sclerosis: Role of Antibodies
por: Berger, Thomas, et al.
Publicado: (2006)

Chemokine Receptors as Biomarkers in Multiple Sclerosis
por: Fox, Robert J., et al.
Publicado: (2006)

Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier
por: Shimizu, Fumitaka, et al.
Publicado: (2014)

Fingolimod Prevents Blood-Brain Barrier Disruption Induced by the Sera from Patients with Multiple Sclerosis
por: Nishihara, Hideaki, et al.
Publicado: (2015)

Preventing Multiple Sclerosis: The Pediatric Perspective
por: Hardy, Duriel, et al.
Publicado: (2022)

Contribution of Tissue Inflammation and Blood-Brain Barrier Disruption to Brain Softening in a Mouse Model of Multiple Sclerosis
por: Silva, Rafaela Vieira, et al.
Publicado: (2021)

Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
por: Zeitelhofer, Manuel, et al.
Publicado: (2020)

Blood–Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis
por: Prell, Tino, et al.
Publicado: (2021)

Is multiple sclerosis a risk factor for infections?
por: Lechner-Scott, Jeannette, et al.
Publicado: (2020)

Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
por: Castillo-Trivino, Tamara, et al.
Publicado: (2013)

Epigenetics in blood–brain barrier disruption
por: Ihezie, Stephanie A., et al.
Publicado: (2021)

Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of Putative Biomarkers
por: O’Connor, Kevin C., et al.
Publicado: (2006)

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
por: Nourbakhsh, Bardia, et al.
Publicado: (2018)

Copy number variations across the blood–brain barrier in multiple sclerosis
por: Bedri, Sahl Khalid, et al.
Publicado: (2022)

Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
por: Verreycken, Janne, et al.
Publicado: (2022)

Decrease of Mutual Information in Brain Electrical Activity of Patients with Relapsing-Remitting Multiple Sclerosis
por: Lenne, Bruno, et al.
Publicado: (2013)

Biosensor vital sign detects multiple sclerosis progression
por: Krysko, Kristen M., et al.
Publicado: (2020)

Pathomechanisms of Blood-Brain Barrier Disruption in ALS
por: Kakaroubas, Nicholas, et al.
Publicado: (2019)

Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis
por: Cao, Maize C., et al.
Publicado: (2022)

One-Year Outcome of Multiple Blood–Brain Barrier Disruptions With Temozolomide for the Treatment of Glioblastoma
por: Park, So Hee, et al.
Publicado: (2020)

The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)

Treatment of Cognitive Impairment in Multiple Sclerosis
por: Pierson, Susan H., et al.
Publicado: (2006)

Laminin as a Biomarker of Blood–Brain Barrier Disruption under Neuroinflammation: A Systematic Review
por: Zapata-Acevedo, Juan F., et al.
Publicado: (2022)

Using an animal model to predict the effective human dose for oral multiple sclerosis drugs
por: Liu, Wei, et al.
Publicado: (2022)

Disruption of blood-brain barrier in Alzheimer disease pathogenesis
por: Kook, Sun-Young, et al.
Publicado: (2013)

Severe Blood–Brain Barrier Disruption in Cardioembolic Stroke
por: Liu, Chang, et al.
Publicado: (2018)

Selective Disruption of the Blood–Brain Barrier by Zika Virus
por: Leda, Ana Rachel, et al.
Publicado: (2019)

Noninvasive disruption of the blood-brain barrier in the marmoset monkey
por: Parks, T. Vincenza, et al.
Publicado: (2023)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis
por: Cramer, Stig P., et al.
Publicado: (2015)

The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier
por: Wei, Shuang-Shuang, et al.
Publicado: (2023)

Effects of a Disrupted Blood-Brain Barrier on Cholesterol Homeostasis in the Brain
por: Saeed, Ahmed A., et al.
Publicado: (2014)

Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood‒brain barrier disruption in anti-NMDA receptor encephalitis
por: Chang, Haoxiao, et al.
Publicado: (2023)

Multiple Sclerosis and the Blood-Central Nervous System Barrier
por: Palmer, Alan M.
Publicado: (2013)

Risk of Multiple Sclerosis in Epstein–Barr Virus Infection
por: Ahmed, Syed Ijlal, et al.
Publicado: (2019)

Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis
por: Salama, Sara, et al.
Publicado: (2020)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_150hig2e6jnd408l7ogvfmhh73